Lowinger Timothy B

Avg. Two Year Performance

No purchase track record

(4%) Avg. Sale Return

(2%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	< 1%	(2%)	4%	5%	(4%)
Sale Success Rate	2 of 13	2 of 13	2 of 13	2 of 13	0 of 13

Mersana Therapeutics, Inc.

Other » Other

SVP, Chief Sci.&Tech. Officer:

Holdings: 199.33K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--